vs
Side-by-side financial comparison of Astrana Health, Inc. (ASTH) and Mobileye Global Inc. (MBLY). Click either name above to swap in a different company.
Astrana Health, Inc. is the larger business by last-quarter revenue ($950.5M vs $558.0M, roughly 1.7× Mobileye Global Inc.). On growth, Astrana Health, Inc. posted the faster year-over-year revenue change (42.9% vs 27.4%). Over the past eight quarters, Astrana Health, Inc.'s revenue compounded faster (53.3% CAGR vs 12.7%).
Astrana Health, Inc. is a U.S.-based value-based healthcare services provider that primarily serves Medicare-eligible senior populations across the United States. It offers in-home primary care, chronic disease management, and care coordination services, aiming to improve patient health outcomes and reduce unnecessary medical costs.
Mobileye Global Inc. is a United States-domiciled, Israel-headquartered autonomous driving company. It is developing self-driving technologies and advanced driver-assistance systems (ADAS) including cameras, computer chips, and software. Mobileye was acquired by Intel in 2017 and went public again in 2022.
ASTH vs MBLY — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $950.5M | $558.0M |
| Net Profit | $6.6M | — |
| Gross Margin | — | 49.3% |
| Operating Margin | 1.9% | -647.5% |
| Net Margin | 0.7% | — |
| Revenue YoY | 42.9% | 27.4% |
| Net Profit YoY | 184.4% | — |
| EPS (diluted) | $0.12 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $558.0M | ||
| Q4 25 | $950.5M | $446.0M | ||
| Q3 25 | $956.0M | $504.0M | ||
| Q2 25 | $654.8M | $506.0M | ||
| Q1 25 | $620.4M | $438.0M | ||
| Q4 24 | $665.2M | $490.0M | ||
| Q3 24 | $478.7M | $486.0M | ||
| Q2 24 | $486.3M | $439.0M |
| Q1 26 | — | — | ||
| Q4 25 | $6.6M | $-127.0M | ||
| Q3 25 | $373.0K | $-96.0M | ||
| Q2 25 | $9.4M | $-67.0M | ||
| Q1 25 | $6.7M | $-102.0M | ||
| Q4 24 | $-7.8M | $-71.0M | ||
| Q3 24 | $16.1M | $-2.7B | ||
| Q2 24 | $19.2M | $-86.0M |
| Q1 26 | — | 49.3% | ||
| Q4 25 | — | 45.3% | ||
| Q3 25 | — | 48.2% | ||
| Q2 25 | — | 49.8% | ||
| Q1 25 | — | 47.3% | ||
| Q4 24 | — | 49.2% | ||
| Q3 24 | — | 48.8% | ||
| Q2 24 | — | 47.6% |
| Q1 26 | — | -647.5% | ||
| Q4 25 | 1.9% | -31.4% | ||
| Q3 25 | 2.0% | -21.6% | ||
| Q2 25 | 3.1% | -14.6% | ||
| Q1 25 | 3.3% | -26.7% | ||
| Q4 24 | 0.1% | -17.6% | ||
| Q3 24 | 5.9% | -577.6% | ||
| Q2 24 | 6.2% | -21.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.7% | -28.5% | ||
| Q3 25 | 0.0% | -19.0% | ||
| Q2 25 | 1.4% | -13.2% | ||
| Q1 25 | 1.1% | -23.3% | ||
| Q4 24 | -1.2% | -14.5% | ||
| Q3 24 | 3.4% | -558.6% | ||
| Q2 24 | 3.9% | -19.6% |
| Q1 26 | — | — | ||
| Q4 25 | $0.12 | $-0.15 | ||
| Q3 25 | $0.01 | $-0.12 | ||
| Q2 25 | $0.19 | $-0.08 | ||
| Q1 25 | $0.14 | $-0.13 | ||
| Q4 24 | $-0.14 | $-0.09 | ||
| Q3 24 | $0.33 | $-3.35 | ||
| Q2 24 | $0.40 | $-0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $429.5M | $1.2B |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $779.3M | $8.2B |
| Total Assets | $2.2B | $8.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.2B | ||
| Q4 25 | $429.5M | $1.8B | ||
| Q3 25 | $463.4M | $1.7B | ||
| Q2 25 | $342.1M | $1.7B | ||
| Q1 25 | $260.9M | $1.5B | ||
| Q4 24 | $290.8M | $1.4B | ||
| Q3 24 | $350.3M | $1.3B | ||
| Q2 24 | $327.7M | $1.2B |
| Q1 26 | — | $8.2B | ||
| Q4 25 | $779.3M | $11.9B | ||
| Q3 25 | $775.5M | $11.9B | ||
| Q2 25 | $765.5M | $12.1B | ||
| Q1 25 | $745.4M | $12.0B | ||
| Q4 24 | $712.7M | $12.1B | ||
| Q3 24 | $704.6M | $12.1B | ||
| Q2 24 | $678.9M | $14.7B |
| Q1 26 | — | $8.7B | ||
| Q4 25 | $2.2B | $12.5B | ||
| Q3 25 | $2.2B | $12.5B | ||
| Q2 25 | $1.4B | $12.6B | ||
| Q1 25 | $1.3B | $12.5B | ||
| Q4 24 | $1.4B | $12.6B | ||
| Q3 24 | $1.3B | $12.6B | ||
| Q2 24 | $1.3B | $15.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-2.9M | $75.0M |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -0.6% | — |
| Capex IntensityCapex / Revenue | 0.3% | — |
| Cash ConversionOCF / Net Profit | -0.44× | — |
| TTM Free Cash FlowTrailing 4 quarters | $104.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $75.0M | ||
| Q4 25 | $-2.9M | $113.0M | ||
| Q3 25 | $10.0M | $167.0M | ||
| Q2 25 | $90.9M | $213.0M | ||
| Q1 25 | $16.6M | $109.0M | ||
| Q4 24 | $-10.9M | $204.0M | ||
| Q3 24 | $34.0M | $126.0M | ||
| Q2 24 | $23.2M | $30.0M |
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $86.0M | ||
| Q3 25 | $7.4M | $143.0M | ||
| Q2 25 | $89.5M | $199.0M | ||
| Q1 25 | $13.6M | $95.0M | ||
| Q4 24 | $-13.5M | $191.0M | ||
| Q3 24 | $31.7M | $104.0M | ||
| Q2 24 | $20.4M | $6.0M |
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 19.3% | ||
| Q3 25 | 0.8% | 28.4% | ||
| Q2 25 | 13.7% | 39.3% | ||
| Q1 25 | 2.2% | 21.7% | ||
| Q4 24 | -2.0% | 39.0% | ||
| Q3 24 | 6.6% | 21.4% | ||
| Q2 24 | 4.2% | 1.4% |
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 6.1% | ||
| Q3 25 | 0.3% | 4.8% | ||
| Q2 25 | 0.2% | 2.8% | ||
| Q1 25 | 0.5% | 3.2% | ||
| Q4 24 | 0.4% | 2.7% | ||
| Q3 24 | 0.5% | 4.5% | ||
| Q2 24 | 0.6% | 5.5% |
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | — | ||
| Q3 25 | 26.69× | — | ||
| Q2 25 | 9.65× | — | ||
| Q1 25 | 2.48× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 1.21× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
MBLY
Segment breakdown not available.
